Abiopharma

New Form 3 - Maze Therapeutics, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001341161-26-000003 <b>Size:</b> 10 KB

New Form 3 - ARS Pharmaceuticals, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0002149973-26-000002 <b>Size:</b> 8 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023934 <b>Size:</b> 969 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001193125-26-354200 <b>Size:</b> 336 KB

New Form 424B3 - Lakewood-Amedex Biotherapeutics Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090808 <b>Size:</b> 418 KB

New Form 6-K/A - Elong Power Holding Ltd. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001493152-26-038763 <b>Size:</b> 330 KB

Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare

Law Offices of Howard G. Smith Encourages Datavault AI, Inc. (DVLT) Shareholders To Inquire About Securities Fraud Class Action

New Form S-8 POS - CYABRA, INC. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090806 <b>Size:</b> 97 KB

📋 Chesley Philip (Officer) plans to sell 5K shares of Qorvo, Inc. (at $97.50 each, total $535K) Filed: Aug 17, 2026 | ID: 006087

New Form SCHEDULE 13D/A - Talkspace, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0000950157-26-000918 <b>Size:</b> 14 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023933 <b>Size:</b> 972 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023932 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001214659-26-010468 <b>Size:</b> 233 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040244 <b>Size:</b> 591 KB